Additional supporting information may be found in the online version of this article at the publisher's web-site.


Figure S1.Concentration–time curves (semi-log scale) for (A) glimepiride, (B) glipizide, and (C) olmesartana following administration of glimepiride, glipizide ER, or olmesartan medoxomil, respectively, alone, with colesevelam, and 4 hours before colesevelam. aFor subjects who participated in both Part 1 and Part 2 of the study, olmesartan concentration data from administration of olmesartan medoxomil alone in Part 1 were included in Part 2 summary statistics for the corresponding treatment.

Table SI. Demographics and Baseline Characteristics

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.